FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Arko Gorter

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Tumor Cells, Cultured

Physiology

Living Beings

Rats
Mouse

Procedures

Co-author Network

Publications

TOP 3
M Schrevel; Natalja T Ter Haar; J B M Z Trimbos; Sjoerd H van der burg; Gert Jan Fleuren; Arko Gorter; R Karim; Ekaterina S. Jordanova
CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients.
Moniek Heusinkveld; Tamara H Ramwadhdoebe; Peggy J de Vos van Steenwijk; Renske Goedemans; Arko Gorter; Thorbald van Hall; Marij J P Welters; Sjoerd H van der burg
M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.
Marlies Schrevel; Arko Gorter; Sandra M Kolkman-Uljee; J Baptist Trimbos; Gert Jan Fleuren; Ekaterina S. Jordanova
Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Arko Gorter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: M Schrevel; Natalja T Ter Haar; J B M Z Trimbos; Sjoerd H van der burg; Gert Jan Fleuren; Arko Gorter; R Karim; Ekaterina S. Jordanova
CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients.
British journal of cancer 2012;106(9):1520-5.
2011: Moniek Heusinkveld; Tamara H Ramwadhdoebe; Peggy J de Vos van Steenwijk; Renske Goedemans; Arko Gorter; Thorbald van Hall; Marij J P Welters; Sjoerd H van der burg
M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.
Journal of immunology (Baltimore, Md. : 1950) 2011;187(3):1157-65.
2011: Marlies Schrevel; Arko Gorter; Sandra M Kolkman-Uljee; J Baptist Trimbos; Gert Jan Fleuren; Ekaterina S. Jordanova
Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(5):720-8.
2011: Evangelia Pardali; D W J van der Schaft; Eliza Wiercinska; Arko Gorter; P C W Hogendoorn; A W Griffioen; Peter ten Dijke
Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma.
Oncogene 2011;30(3):334-45.
2010: Arko Gorter; Henry J M A A Zijlmans; Hestia van Gent; J Baptist Trimbos; Gert J Fleuren; Ekaterina S. Jordanova
Versican expression is associated with tumor-infiltrating CD8-positive T cells and infiltration depth in cervical cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(12):1605-15.
2008: J N Kloth; Arko Gorter; G J Fleuren; Jan Oosting; S Uljee; N ter Haar; E J Dreef; G G Kenter; Ekaterina S. Jordanova
Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
The Journal of pathology 2008;215(3):222-30.
2008: Judith N Kloth; Gemma G Kenter; H Siebe Spijker; Sandra Uljee; Willem E Corver; Ekaterina S. Jordanova; Gert Jan Fleuren; Arko Gorter
Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(7):866-75.
2008: Ekaterina S. Jordanova; Arko Gorter; Ouissam Ayachi; Frans A Prins; Lindy G Durrant; Gemma G Kenter; Sjoerd H van der burg; Gert Jan Fleuren
Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):2028-35.
2008: Cornelis FM Sier; Lukas J A C Hawinkels; Henry J M A A Zijlmans; Kim Zuidwijk; Eveline S M de Jonge-Muller; Valerie Ferreira; roeland hanemaaijer; Adri A Mulder-Stapel; Gemma G Kenter; Hein Verspaget; Arko Gorter
Endothelium specific matrilysin (MMP-7) expression in human cancers.
Matrix biology : journal of the International Society for Matrix Biology 2008;27(3):267-71.
2008: Judith N Kloth; Arko Gorter; Natalja T Ter Haar; Willem E Corver; Ekaterina S. Jordanova; Gemma G Kenter; Gert Jan Fleuren
Lack of TNFalpha mRNA expression in cervical cancer is not associated with loss of heterozygosity at 6p21.3, inactivating mutations or promoter methylation.
Molecular immunology 2008;45(1):152-9.
2007: Suzanne Hazelbag; Gemma G Kenter; Arko Gorter; Enno J Dreef; LA Koopman; Shelia M Violette; Paul H Weinreb; Gert Jan Fleuren
Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
The Journal of pathology 2007;212(3):316-24.
2007: Henry J M A A Zijlmans; Gert Jan Fleuren; Hans J Baelde; Paul H C Eilers; Gemma G Kenter; Arko Gorter
Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma.
Cancer 2007;109(3):556-65.
2007: Judith N Kloth; Jan Oosting; Tom van Wezel; Karoly Szuhai; Jeroen Knijnenburg; Arko Gorter; Gemma G Kenter; Gert Jan Fleuren; Ekaterina S. Jordanova
Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
BMC genomics 2007;8():53.
2006: Cornelis FM Sier; Kim Zuidwijk; Henry J M A A Zijlmans; roeland hanemaaijer; Adri A Mulder-Stapel; Frans A Prins; Enno J Dreef; Gemma G Kenter; Gert Jan Fleuren; Arko Gorter
EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma.
International journal of cancer. Journal international du cancer 2006;118(12):2991-8.
2006: Kyra A Gelderman; Suzanne Lam; Cornelis FM Sier; Arko Gorter
Cross-linking tumor cells with effector cells via CD55 with a bispecific mAb induces beta-glucan-dependent CR3-dependent cellular cytotoxicity.
European journal of immunology 2006;36(4):977-84.
2006: Henry J M A A Zijlmans; Gert Jan Fleuren; Hans J Baelde; Paul H C Eilers; Gemma G Kenter; Arko Gorter
The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2.
The Journal of pathology 2006;208(4):507-17.
2005: Kyra A Gelderman; Suzanne Lam; Arko Gorter
Inhibiting complement regulators in cancer immunotherapy with bispecific mAbs.
Expert opinion on biological therapy 2005;5(12):1593-601.
2005: Judith N Kloth; Gert Jan Fleuren; Jan Oosting; Renée X de Menezes; Paul H C Eilers; Gemma G Kenter; Arko Gorter
Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
Carcinogenesis 2005;26(9):1493-502.
2004: Suzanne Hazelbag; Gemma G Kenter; Arko Gorter; Gert Jan Fleuren
Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
International journal of cancer. Journal international du cancer 2004;112(6):1020-8.
2004: Kyra A Gelderman; Peter Kuppen; Noriko Okada; Gert Jan Fleuren; Arko Gorter
Tumor-specific inhibition of membrane-bound complement regulatory protein Crry with bispecific monoclonal antibodies prevents tumor outgrowth in a rat colorectal cancer lung metastases model.
Cancer research 2004;64(12):4366-72.
2004: Cornelis FM Sier; Kyra A Gelderman; Frans A Prins; Arko Gorter
Beta-glucan enhanced killing of renal cell carcinoma micrometastases by monoclonal antibody G250 directed complement activation.
International journal of cancer. Journal international du cancer 2004;109(6):900-8.
2004: Kyra A Gelderman; Henry J M A A Zijlmans; Marcel J Vonk; Arko Gorter
CD55 expression patterns on intestinal neuronal tissue are divergent from the brain.
Gut 2004;53(4):507-13.
2004: Kyra A Gelderman; Stephen Tomlinson; Gordon D Ross; Arko Gorter
Complement function in mAb-mediated cancer immunotherapy.
Trends in immunology 2004;25(3):158-64.
2003: Kyra A Gelderman; J Hakulinen; Muriel A Hagenaars; Peter Kuppen; S Meri; Arko Gorter
Membrane-bound complement regulatory proteins inhibit complement activation by an immunotherapeutic mAb in a syngeneic rat colorectal cancer model.
Molecular immunology 2003;40(1):13-23.
2003: Gerben A Koning; Henriëtte W M Morselt; Arko Gorter; Theresa M Allen; Samuel Zalipsky; Gerrit L Scherphof; Jan A A M Kamps
Interaction of differently designed immunoliposomes with colon cancer cells and Kupffer cells. An in vitro comparison.
Pharmaceutical research 2003;20(8):1249-57.
2003: Vanessa T Blok; Kyra A Gelderman; Odette Tijsma; Mohamed R Daha; Arko Gorter
Cytokines affect resistance of human renal tumour cells to complement-mediated injury.
Scandinavian journal of immunology 2003;57(6):591-9.
2002: Suzanne Hazelbag; Arko Gorter; Gemma G Kenter; L J C M van den Broek; Gert Jan Fleuren
Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer.
Human pathology 2002;33(12):1193-9.
2002: Kyra A Gelderman; Vanessa T Blok; Gert Jan Fleuren; Arko Gorter
The inhibitory effect of CD46, CD55, and CD59 on complement activation after immunotherapeutic treatment of cervical carcinoma cells with monoclonal antibodies or bispecific monoclonal antibodies.
Laboratory investigation; a journal of technical methods and pathology 2002;82(4):483-93.
2002: Kyra A Gelderman; Peter Kuppen; Wouter Bruin; Gert Jan Fleuren; Arko Gorter
Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma.
European journal of immunology 2002;32(1):128-35.
2001: Peter Kuppen; Arko Gorter; Muriel A Hagenaars; Liesbeth E Jonges; KM Giezeman-Smits; J Fred Nagelkerke; Gert Jan Fleuren; Cornelis J H van de Velde
Role of NK cells in adoptive immunotherapy of metastatic colorectal cancer in a syngeneic rat model.
Immunological reviews 2001;184():236-43.
2001: Suzanne Hazelbag; Gert Jan Fleuren; JJ Baelde; E Schuuring; Gemma G Kenter; Arko Gorter
Cytokine profile of cervical cancer cells.
Gynecologic oncology 2001;83(2):235-43.
2001: Jan Paul Medema; J de Jong; Lucy T C Peltenburg; Els Verdegaal; Arko Gorter; Sandra A Bres; Kees L M C Franken; Michael Hahne; Juan Pablo Albar; Cornelis J M Melief; Rienk Offringa
Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(20):11515-20.
2001: Gerben A Koning; Henriëtte W M Morselt; Arko Gorter; Theresa M Allen; Samuel Zalipsky; Jan A A M Kamps; Gerrit L Scherphof
Pharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastases.
Pharmaceutical research 2001;18(9):1291-8.
2000: Vanessa T Blok; Mohamed R Daha; O M Tijsma; M G Weissglas; L J C M van den Broek; Arko Gorter
A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage.
Laboratory investigation; a journal of technical methods and pathology 2000;80(3):335-44.
2000: Jan A A M Kamps; Gerben A Koning; Maria J Velinova; Henriëtte W M Morselt; M Wilkens; Arko Gorter; J Donga; Gerrit L Scherphof
Uptake of long-circulating immunoliposomes, directed against colon adenocarcinoma cells, by liver metastases of colon cancer.
Journal of drug targeting 2000;8(4):235-45.
1999: Arko Gorter; S Meri
Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
Immunology today 1999;20(12):576-82.
1999: Gerben A Koning; Henriëtte W M Morselt; Maria J Velinova; J Donga; Arko Gorter; Theresa M Allen; Samuel Zalipsky; Jan A A M Kamps; Gerrit L Scherphof
Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells.
Biochimica et biophysica acta 1999;1420(1-2):153-67.
1999: Gerben A Koning; Arko Gorter; Gerrit L Scherphof; Jan A A M Kamps
Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells.
British journal of cancer 1999;80(11):1718-25.
1999: KM Giezeman-Smits; Arko Gorter; Ronald L P van Vlierberghe; J D v Eendenburg; Alexander M M Eggermont; Gert Jan Fleuren; Peter Kuppen
The regulatory role of CD45 on rat NK cells in target cell lysis.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(1):71-6.
1998: Vanessa T Blok; Mohamed R Daha; Odette Tijsma; C L Harris; B P Morgan; Gert Jan Fleuren; Arko Gorter
A bispecific monoclonal antibody directed against both the membrane-bound complement regulator CD55 and the renal tumor-associated antigen G250 enhances C3 deposition and tumor cell lysis by complement.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(7):3437-43.
1997: KM Giezeman-Smits; Arko Gorter; J Fred Nagelkerke; Ronald L P van Vlierberghe; Jaap van Eendenburg; Alexander M M Eggermont; Gert Jan Fleuren; Peter Kuppen
Characterization of three new membrane structures on rat NK cells which are involved in activation of the lytic machinery.
Immunobiology 1997;197(5):429-43.
1997: DJ Blom; WR Goslings; I de Waard-Siebinga; Gregorius P M Luyten; Frans H J Claas; Arko Gorter; Martine J Jager
Lack of effect of different cytokines on expression of membrane-bound regulators of complement activity on human uveal melanoma cells.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1997;17(11):695-700.
1996: Mieneke G A van Dixhoorn; Arko Gorter; T Sato; A M van der Wal; Jaap van Eendenburg; Jan Rozing; Mohamed R Daha; Emile de Heer
Induction of microhematuria by an IgA isotype switch variant of a monoclonal anti-Thy-1.1 antibody in the rat.
Kidney international 1996;50(5):1612-23.
1996: W R Goslings; DJ Blom; I de Waard-Siebinga; E van Beelen; Frans H J Claas; Martine J Jager; Arko Gorter
Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
Investigative ophthalmology & visual science 1996;37(9):1884-91.
1996: Arko Gorter; V T Blok; W H Haasnoot; N G Ensink; Mohamed R Daha; Gert Jan Fleuren
Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Laboratory investigation; a journal of technical methods and pathology 1996;74(6):1039-49.
1995: Gert Jan Fleuren; Arko Gorter; Peter Kuppen; Sergey V Litvinov; SO Warnaar
Tumor heterogeneity and immunotherapy of cancer.
Immunological reviews 1995;145():91-122.
1994: M P Velders; Sergey V Litvinov; SO Warnaar; Arko Gorter; Gert Jan Fleuren; V R Zurawski; L R Coney
New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.
Cancer research 1994;54(7):1753-9.
1993: Arko Gorter; R J van de Griend; Jaap van Eendenburg; W H Haasnoot; Gert Jan Fleuren
Production of bi-specific monoclonal antibodies in a hollow-fibre bioreactor.
Journal of immunological methods 1993;161(2):145-50.
1993: G D Beun; Arko Gorter; Y Nooyen; Cornelis J H van de Velde; Gert Jan Fleuren
T cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. II. Syngeneic colon carcinoma CC531 is efficiently killed by retargeted cytotoxic T lymphocytes in vitro despite limited lysis in 51Cr release assays.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(6):2305-15.
1992: Arko Gorter; K M Krüse; Peter I Schrier; Gert Jan Fleuren; R J van de Griend
Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies.
Clinical and experimental immunology 1992;87(1):111-6.